Allergy Technologies created ATAHC, a proven program that significantly reduces hard-to-control bed bugs among the nation’s most vulnerable residents and provides benefits to a wide range of stakeholders. Prior to the implementation of this proactive, preventative program, the study’s 470 affordable housing community in Philadelphia reported more than 80-90 bed bug cases annually.
PMPs will reap the benefits of the program, which provides an affordable and sustainable bed bug control and prevention model for their residential customers.
“In addition to revenue growth, PMPs are addressing a tremendous unmet need in this market while improving the quality of life for their customers and their residents,” said Charles Cerbini, executive vice president, technical director, Corbett Exterminating, whose firm led the first landmark program. “There is a tremendous growth opportunity for PMPs in apartment buildings where bed bugs persist. And frankly, that’s everywhere.”
ATAHC differs from other approaches by providing initial facility-wide screening and subsequent treatment of infested dwellings, reducing the bed bug population immediately. The installation of long-acting preventive measures throughout the property, including ActiveGuard mattress pads, which are the only EPA-registered retail product labeled to prevent bed bug infestations for two years, ensures that the bed bug population remains under control.
According to Gus Carey, founder and CEO of Allergy Technologies, “Affordable home residents are now prepared to see their lives transformed thanks to our groundbreaking ATAHC program.”
Unique to ATAHC is the focus on the dignity and self-esteem of residents, who are often negatively impacted by the stigma of bed bugs in community living environments. Education through presentations by HUD-sponsored professionals; Distribution of easy-to-understand material dispelling the myths about this pest in the residents’ native languages; and a general sensitivity to cultural diversity are all cornerstones to increase resident engagement with the program.
“Early detection and early intervention are core tenets of the ATAHC program,” said Allergy Technologies President Joseph Latino, “allowing for less disruptive and more cost-effective localized treatments.” as a result, our ATAHC team works with residents, property management and professional pest control providers.”
The ATAHC program has virtually eliminated bed bug incidents affecting residents and staff.
“Current treatment strategies aren’t working,” Latino continued. “Bed bug infestations continue to rise across the country, particularly in shared accommodation. We consider this to be unacceptable, especially for residents whose quality of life is severely impaired. We had the resources to address this nationwide problem and developed the ATAHC program, the results of which have exceeded even our expectations.”
Carey concluded, “We were able to provide a solution to a major unmet need in an environment in dire need of effective bed bug prevention. We expect this novel strategic program, which has saved money while significantly improving the quality of life for residents and staff, to be replicated in affordable shared communities and other multi-resident communities across the United States.”
In 2022 and 2023, Allergy Technologies will roll out the ATAHC program for implementation in affordable housing and other multi-family homes across the country.
For more details, visit Allergy Technologies’ website at: www.AllergyTechnologies.com.
